Form 8-K - Current report:
SEC Accession No. 0001279569-21-001374
Filing Date
2021-10-08
Accepted
2021-10-08 14:06:11
Documents
17
Period of Report
2021-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 40848
2 AGREEMENT AND PLAN OF MERGER, DATED AS OF OCTOBER 6, 2021 ex101.htm EX-10.1 310153
3 MEMBERSHIP INTEREST PURCHASE AGREEMENT, DATED AS OF OCTOBER 6, 2021 ex102.htm EX-10.2 182347
4 CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT, DATED AS OF OCTOBER 6, 2021 ex103.htm EX-10.3 152116
5 NEWS RELEASE DATED OCTOBER 7, 2021 ex991.htm EX-99.1 12467
6 GRAPHIC image_001.jpg GRAPHIC 1750
  Complete submission text file 0001279569-21-001374.txt   1035764

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20211006.xsd EX-101.SCH 3046
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20211006_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20211006_pre.xml EX-101.PRE 22372
10 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3565
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 211314905
SIC: 2833 Medicinal Chemicals & Botanical Products